BRPI0820198A2 - composições farmacêuticas - Google Patents

composições farmacêuticas

Info

Publication number: BRPI0820198A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical compositions; pharmaceutical; compositions
Prior art date: 2007-11-12

Application number

BRPI0820198A

Other languages

English (en)

Inventor

Harasymiw George

Lawrence Zielinski Joseph

Frank Wagner Robert

Talamonti Wayne

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-12

Filing date

2008-11-10

Publication date

2019-09-24

2008-11-10 Application filed by Novartis Ag filed Critical Novartis Ag

2019-09-24 Publication of BRPI0820198A2 publication Critical patent/BRPI0820198A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0820198A 2007-11-12 2008-11-10 composições farmacêuticas BRPI0820198A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US98717807P	2007-11-12	2007-11-12
PCT/US2008/082932 WO2009064681A2 (en)	2007-11-12	2008-11-10	Liquid compositions comprising valsartan

Publications (1)

Publication Number	Publication Date
BRPI0820198A2 true BRPI0820198A2 (pt)	2019-09-24

Family

ID=40639403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820198A BRPI0820198A2 (pt)	2007-11-12	2008-11-10	composições farmacêuticas

Country Status (10)

Country	Link
US (2)	US20100267787A1 (pt)
EP (2)	EP2222273A2 (pt)
JP (1)	JP2011503105A (pt)
KR (1)	KR20100087002A (pt)
CN (1)	CN101854913A (pt)
BR (1)	BRPI0820198A2 (pt)
CA (1)	CA2705453A1 (pt)
MX (1)	MX2010005198A (pt)
RU (2)	RU2488393C2 (pt)
WO (1)	WO2009064681A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6200893B2 (ja)	2011-10-31	2017-09-20	ノバルティスアーゲー	パゾパニブ製剤
KR20140108652A (ko) *	2011-12-26	2014-09-12	노파르티스 아게	정제 및 건식-코팅된 작용제
ES2584248B1 (es) *	2015-03-24	2017-04-19	Farmalider, S.A.	Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral
CN105596305A (zh) *	2015-12-25	2016-05-25	华润赛科药业有限责任公司	一种高稳定性的缬沙坦制剂及其制备方法
WO2017191619A2 (en) *	2016-05-06	2017-11-09	Sun Pharmaceutical Industries Limited	A process for the preparation of a salt of sacubitril and valsartan
WO2018204040A1 (en) *	2017-05-01	2018-11-08	Bioramo, Llc	Oral liquid compositions of valsartan
US11413275B1 (en)	2018-12-14	2022-08-16	ECI Pharmaceuticals, LLC	Oral liquid compositions including valsartan
US10478422B1 (en)	2018-12-14	2019-11-19	ECI Pharmaceuticals, LLC	Oral liquid compositions including valsartan
US10548838B1 (en)	2018-12-14	2020-02-04	ECI Pharmaceuticals, LLC	Oral liquid compositions including valsartan
US11446243B1 (en)	2019-08-05	2022-09-20	ECI Pharmaceuticals, LLC	Oral liquid compositions including valsartan

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE122010000024I1 (de)	1990-02-19	2010-07-08	Novartis Ag	Acylverbindungen
GB9200247D0 (en) *	1992-01-07	1992-02-26	Erba Carlo Spa	Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
MY152846A (en)	2000-07-19	2014-11-28	Novartis Ag	New salts of valsartan
JP2006501134A (ja) *	2001-12-20	2006-01-12	ブリストル−マイヤーズ　スクイブ　カンパニー	高い生物学的利用能を有する、経口活性タキサン誘導体の医薬組成物
US20040247588A1 (en) *	2002-08-28	2004-12-09	Johnson Robert E.	Formulations of modified antibodies and methods of making the same
TWI327913B (en) *	2003-03-12	2010-08-01	Novartis Ag	Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
JP2007512345A (ja) *	2003-11-21	2007-05-17	シェーリング　コーポレイション	ホスホジエステラーゼｖ阻害剤処方物
US20070026026A1 (en) *	2005-08-01	2007-02-01	David Delmarre	Oral liquid losartan compositions
RU2487710C2 (ru) *	2007-10-09	2013-07-20	Новартис Аг	Фармацевтическая композиция валсартана

2008
- 2008-11-10 KR KR1020107010332A patent/KR20100087002A/ko not_active Withdrawn
- 2008-11-10 US US12/741,857 patent/US20100267787A1/en not_active Abandoned
- 2008-11-10 CN CN200880115379A patent/CN101854913A/zh active Pending
- 2008-11-10 EP EP08850984A patent/EP2222273A2/en not_active Withdrawn
- 2008-11-10 WO PCT/US2008/082932 patent/WO2009064681A2/en active Application Filing
- 2008-11-10 RU RU2010123691/15A patent/RU2488393C2/ru not_active IP Right Cessation
- 2008-11-10 EP EP10177744A patent/EP2316422A1/en not_active Withdrawn
- 2008-11-10 MX MX2010005198A patent/MX2010005198A/es unknown
- 2008-11-10 CA CA2705453A patent/CA2705453A1/en not_active Abandoned
- 2008-11-10 JP JP2010533312A patent/JP2011503105A/ja active Pending
- 2008-11-10 BR BRPI0820198A patent/BRPI0820198A2/pt not_active IP Right Cessation
2012
- 2012-12-20 US US13/721,521 patent/US20130109729A1/en not_active Abandoned
2013
- 2013-01-11 RU RU2013101018/15A patent/RU2013101018A/ru unknown

Also Published As

Publication number	Publication date
AU2008321159A1 (en)	2009-05-22
RU2010123691A (ru)	2011-12-20
RU2488393C2 (ru)	2013-07-27
EP2316422A1 (en)	2011-05-04
JP2011503105A (ja)	2011-01-27
CA2705453A1 (en)	2009-05-11
US20100267787A1 (en)	2010-10-21
RU2013101018A (ru)	2014-07-20
WO2009064681A2 (en)	2009-05-22
US20130109729A1 (en)	2013-05-02
MX2010005198A (es)	2010-05-20
KR20100087002A (ko)	2010-08-02
WO2009064681A3 (en)	2009-10-08
CN101854913A (zh)	2010-10-06
EP2222273A2 (en)	2010-09-01

Publication	Publication Date	Title
LTC2140867I2 (lt)	2018-11-12	Farmacinė kompozicija
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
RU2493831C3 (ru)	2017-06-08	Фармацевтические композиции
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
SMT201600259B (it)	2016-08-31	Composizioni farmaceutiche antibatteriche
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
DK2079456T3 (da)	2013-03-18	Farmaceutiske cyclosporinsammensætninger
ME01423B (me)	2013-12-20	Fungicidni sastavi
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
EP2191826A4 (en)	2010-09-15	PHARMACEUTICAL COMPOSITION
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
BRPI1012539A2 (pt)	2016-03-29	composições farmacêuticas
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
IT1394400B1 (it)	2012-06-15	Composizioni farmaceutiche
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BR112012001340A2 (pt)	2016-03-15	composições farmacêuticas
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica
DK2271321T3 (da)	2012-08-27	Farmaceutisk sammensætning 271

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.